Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Azienda Ospedaliero-Universitaria Maggiore Della Carita
Sponsor

Azienda Ospedaliero-Universitaria Maggiore Della Carita

Italy Corso Giuseppe Mazzini 18, 28100 Novara, Italy

About the sponsor

Clinical research at Azienda Ospedaliero-Universitaria Maggiore Della Carita includes acute myocardial infarction, ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina. The sponsor also studies primary percutaneous coronary intervention and coronary plaque inflammation, with attention to platelet reactivity, heart failure, and myocardial injury.

  • Acute coronary syndromes
  • Myocardial infarction
  • Coronary intervention
  • Antiplatelet therapy

Research activity in this area reflects a focus on cardiometabolic risk and treatment strategies relevant to hospitalized patients with acute ischemic heart disease.

About Specializations

Azienda Ospedaliero-Universitaria Maggiore Della Carita runs clinical trials in conditions such as Acute myocardial infarction, Amyotrophic lateral sclerosis, Dementia Alzheimer's type, Parkinson's disease, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Amyotrophic lateral sclerosis+2

Recruiting

Study on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer's, Parkinson's, or ALS Using Dronabinol and Cannabidiol

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cannabidiol
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Diabetes mellitus+2

Not yet recruiting

A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Acute myocardial infarction

Not yet recruiting

Study of early dapagliflozin treatment to reduce heart damage in patients with acute heart attack and reduced heart pumping function

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Pneumonia bacterial+5

Not yet recruiting

Study of vitamin D3 (cholecalciferol) as additional treatment for elderly patients with pneumonia or sepsis due to infection

Registered drug
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Colecalciferol
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Acute myocardial infarction+1

Not recruiting

Study on Early vs. Delayed Ticagrelor with Cangrelor for Patients with STEMI Undergoing PCI

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ticagrelor
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.